CRISIL Ltd. Valuation Shifts to Very Expensive Amid Mixed Returns

Valuation Metrics Signal Elevated Price Levels

As of 24 Aug 2026, CRISIL’s P/E ratio stands at 37.46, a significant premium compared to its industry peers. For context, CARE Ratings, another capital markets firm, trades at a P/E of 28.29, while ICRA’s P/E is considerably lower at 24.34. This places CRISIL firmly in the 'very expensive' valuation bracket, a shift from its previous 'expensive' status. The price-to-book value ratio of 10.13 further underscores the stock’s elevated valuation, indicating investors are paying over ten times the company’s book value.

Other valuation multiples reinforce this premium stance. The enterprise value to EBITDA (EV/EBITDA) ratio is 26.48, higher than CARE Ratings’ 24.01 and well above ICRA’s 17.54. Similarly, the EV to EBIT ratio of 30.13 and EV to capital employed at 12.10 reflect a stretched valuation relative to earnings and capital base. The PEG ratio, which adjusts the P/E for growth, is 1.74, suggesting that while growth expectations are factored in, the stock remains pricey compared to peers.

Financial Performance and Returns: A Mixed Picture

CRISIL’s operational metrics remain robust, with a return on capital employed (ROCE) of 40.16% and return on equity (ROE) of 27.03%, both indicative of strong profitability and efficient capital utilisation. The dividend yield, however, is modest at 1.39%, which may be less attractive for income-focused investors.

Examining stock returns relative to the benchmark Sensex reveals a nuanced performance. Over the past week, CRISIL gained 0.75%, outperforming the Sensex’s decline of 0.60%. The one-month return is even more impressive at 4.91%, compared to the Sensex’s marginal 0.09% gain. Year-to-date, CRISIL has delivered a positive 4.35% return, while the Sensex has declined by 9.01%, highlighting relative resilience.

However, longer-term returns tell a different story. Over the past year, CRISIL’s stock has fallen 16.39%, underperforming the Sensex’s 5.44% decline. Over three years, CRISIL’s 14.11% return lags the Sensex’s 18.90%, though the five-year return of 71.61% comfortably outpaces the Sensex’s 40.14%. The ten-year return of 111.55% remains below the Sensex’s 176.17%, suggesting that while CRISIL has delivered solid gains, it has not matched the broader market’s long-term growth.

Mojo Grade Upgrade Reflects Improved Sentiment but Valuation Remains a Concern

On 11 Aug 2026, CRISIL’s Mojo Grade was upgraded from Sell to Hold, with a current Mojo Score of 54.0. This upgrade signals a more favourable outlook on the stock’s near-term prospects, likely driven by its recent price resilience and operational strength. However, the valuation grade has simultaneously shifted from 'expensive' to 'very expensive', indicating that the stock’s price now demands a premium that may limit upside potential.

CRISIL’s market capitalisation classifies it as a small-cap stock, which often entails higher volatility and growth potential but also greater risk. The stock’s day change of 0.77% on 24 Aug 2026 suggests moderate investor interest and positive momentum.

Comparative Analysis with Peers

When compared with its closest competitors in the capital markets sector, CRISIL’s valuation multiples stand out. CARE Ratings, also rated 'very expensive', trades at a lower P/E of 28.29 and EV/EBITDA of 24.01, while ICRA, rated 'expensive', offers a more attractive valuation with a P/E of 24.34 and EV/EBITDA of 17.54. The PEG ratio of CARE Ratings is 1.16, significantly below CRISIL’s 1.74, suggesting that CARE’s valuation is more justified by growth expectations.

This comparative premium for CRISIL may reflect its stronger profitability metrics, brand recognition, or market positioning, but it also raises questions about the sustainability of its current price levels, especially given the broader market’s mixed performance.

Price Range and Market Dynamics

CRISIL’s current price of ₹4,513.15 is close to its recent high of ₹5,422.00 over the past 52 weeks, with a low of ₹3,689.00 during the same period. The stock’s intraday range on 24 Aug 2026 was between ₹4,468.10 and ₹4,530.00, reflecting moderate volatility. This price action suggests that while the stock has recovered from its lows, it faces resistance near its upper band, consistent with its stretched valuation.

Investors should weigh the company’s strong operational metrics and relative outperformance over short-term periods against the premium valuation and subdued longer-term returns. The capital markets sector itself has experienced varied performance, and CRISIL’s positioning within this context is critical for portfolio decisions.

Conclusion: Valuation Premium Warrants Caution

CRISIL Ltd.’s transition to a 'very expensive' valuation grade, driven by elevated P/E and P/BV ratios, highlights a significant shift in price attractiveness. While the company’s profitability and recent relative returns justify some premium, the stretched multiples compared to peers and historical benchmarks suggest limited margin for error. The Mojo Grade upgrade to Hold reflects improved sentiment but does not fully mitigate valuation concerns.

Investors should consider these factors carefully, balancing CRISIL’s operational strengths against its high valuation and mixed long-term returns. Diversification and comparison with sector peers remain essential to optimise portfolio outcomes in the capital markets space.

Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today